Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases - Anorectal anomalies - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-02-01 04:42:51 Chemistry Medicine Clinical medicine Breakthrough therapy Carbamates Cyclopropanes Infectious causes of cancer Sulfonamides Simeprevir Sofosbuvir Ombitasvir/paritaprevir/ritonavir Telaprevir		Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases Add to Reading List Source URL: www.hepatitis-schweiz.ch Download Document from Source Website File Size: 142,28 KB Share Document on Facebook

	Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases DocID: 1qOAQ - View Document
	NIH Public Access Author Manuscript Haemophilia. Author manuscript; available in PMC 2015 September 01. NIH-PA Author Manuscript DocID: 1qx0K - View Document
	--------------------------------CONTRAINDICATIONS----------------------------- EPCLUSA and ribavirin combination regimen is contraindicated in patients for whom ribavirin is contraindicated (4) HIGHLIGHTS OF PRESCRIBIN DocID: 1qjt9 - View Document
	Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases DocID: 1qfUf - View Document
	Guidelines EASL Recommendations on Treatment of Hepatitis C 2015 European Association for the Study of the Liver ⇑ Introduction DocID: 1pRH9 - View Document